— Know what they know.
Not Investment Advice
Also trades as: ENDPQ (OTC) · $vol 0M · 0Y5F.L (LSE) · $vol 0M

ENDP NASDAQ

Endo International plc
1W: -27.9% 1M: -35.1% 3M: -26.4% 1Y: -88.4% 3Y: -90.0% 5Y: -96.5%
$0.37
Last traded 2022-08-25 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$3.0B +3.1% ▲
5Y CAGR: -5.7%
Gross Profit
$1.8B +21.3% ▲
5Y CAGR: +5.2%
Operating Income
$16M -97.4% ▼
Net Income
-$569M -409.4% ▼
EPS (Diluted)
$-2.44 -408.9% ▼
EBITDA
$1.1B +2.7% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2017FY2018FY2019FY2020FY2021
Revenue$3.5B$2.9B$2.9B$2.9B$3.0B
YoY Growth-13.5%-15.0%-1.1%-0.4%+3.1%
Cost of Revenue$2.2B$1.6B$1.6B$1.4B$1.2B
Gross Profit$1.2B$1.3B$1.3B$1.5B$1.8B
Gross Margin35.8%44.6%46.2%50.3%59.2%
R&D Expenses$172M$186M$131M$159M$149M
SG&A Expenses$630M$646M$632M$699M$862M
Operating Expenses$802M$832M$763M$857M$1.0B
Operating Income-$960M-$469M$582M$603M$16M
Operating Margin-27.7%-15.9%20.0%20.8%0.5%
Interest Expense$495M$535M$559M$537M$562M
Income Before Tax-$1.5B-$939M-$407M-$90M-$547M
Tax Expense-$250M$23M$16M-$274M$22M
Net Income-$2.0B-$1.0B-$423M$184M-$569M
Net Margin-58.7%-35.0%-14.5%6.3%-19.0%
EPS (Diluted)$-9.12$-4.61$-1.87$0.79$-2.44
EBITDA-$807M$250M$1.8B$1.0B$1.1B
Shares Outstanding223M224M226M234M233M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms